• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病中的细胞外基质改变

Extracellular matrix alterations in the Peyronie's disease.

作者信息

Watanabe Marcelo Silva, Theodoro Thérèse Rachel, Coelho Natália Lima, Mendes Aline, Leonel Monica Luzia Pereira, Mader Ana Maria, Nader Helena Bonciani, Glina Sidney, Pinhal Maria Aparecida Silva

机构信息

Biochemistry Departament, Faculdade de Medicina do ABC, Santo André 09060-650, Brazil.

Biochemistry Department Universidade Federal de São Paulo, UNIFESP, São Paulo 04044-020, Brazil.

出版信息

J Adv Res. 2017 Jul;8(4):455-461. doi: 10.1016/j.jare.2017.06.004. Epub 2017 Jun 15.

DOI:10.1016/j.jare.2017.06.004
PMID:28721300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5491452/
Abstract

Peyronie's disease is characterized by fibrous plaque formation of the tunica albuginea, causing penile deformity and fertility problems. The aim of the present study was to investigate alterations in the extracellular matrix in Peyronie's disease. The study used tissues collected by surgical procedure from individuals that presented a well-established disease, while control samples were obtained by biopsies of fresh cadavers. Immunohistochemistry analysis followed by digital quantification was performed to evaluate TGF-β, heparanases and metalloproteinases (MMPs). The profile of sulfated glycosaminoglycans, chondroitin sulfate and dermatan sulfate was determined by agarose gel electrophoresis, while hyaluronic acid quantification was obtained by an ELISA-like assay. The expression of mRNA was investigated for syndecan-1 proteoglycan (Syn-1), interleukine-6 (IL-6), hyaluronic acid synthases, and hyaluronidases. Pathologic features showed decreased apoptosis and blood vessel number in Peyronie's tissues. TGF-β and IL-6 were significantly enhanced in Peyronie's disease. There was an increased expression of heparanases, though no alteration was observed for MMPs. Hyaluronic acid as well as hyaluronic acid synthases, hyaluronidases, and dermatan sulfate were not changed, while the level of chondroitin sulfate was significantly ( = 0.008, Mann-Whitney test) increased in Peyronie's samples. Heparanases and sulfated glycosaminoglycans seem to be involved in extracellular matrix alterations in Peyronie's disease.

摘要

佩罗尼氏病的特征是白膜形成纤维斑块,导致阴茎畸形和生育问题。本研究的目的是调查佩罗尼氏病细胞外基质的变化。该研究使用通过手术程序从患有确诊疾病的个体收集的组织,而对照样本则通过新鲜尸体活检获得。进行免疫组织化学分析并随后进行数字定量,以评估转化生长因子-β(TGF-β)、乙酰肝素酶和金属蛋白酶(MMPs)。通过琼脂糖凝胶电泳确定硫酸化糖胺聚糖、硫酸软骨素和硫酸皮肤素的概况,而透明质酸定量则通过类似酶联免疫吸附测定(ELISA)的方法获得。研究了syndecan-1蛋白聚糖(Syn-1)、白细胞介素-6(IL-6)、透明质酸合成酶和透明质酸酶的mRNA表达。病理特征显示佩罗尼氏病组织中的细胞凋亡和血管数量减少。TGF-β和IL-6在佩罗尼氏病中显著增强。乙酰肝素酶的表达增加,而MMPs未观察到变化。透明质酸以及透明质酸合成酶、透明质酸酶和硫酸皮肤素没有变化,而硫酸软骨素水平在佩罗尼氏病样本中显著升高(曼-惠特尼检验,P = 0.008)。乙酰肝素酶和硫酸化糖胺聚糖似乎参与了佩罗尼氏病的细胞外基质改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/febd977643ec/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/bf2cdb038495/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/1e1e4200c8e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/1e6735ff09ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/55a53761a0b0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/7d227fb716c4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/0cf831792588/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/a86969b56795/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/febd977643ec/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/bf2cdb038495/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/1e1e4200c8e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/1e6735ff09ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/55a53761a0b0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/7d227fb716c4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/0cf831792588/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/a86969b56795/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af77/5491452/febd977643ec/gr7.jpg

相似文献

1
Extracellular matrix alterations in the Peyronie's disease.佩罗尼氏病中的细胞外基质改变
J Adv Res. 2017 Jul;8(4):455-461. doi: 10.1016/j.jare.2017.06.004. Epub 2017 Jun 15.
2
Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts.白细胞介素-1β和转化生长因子-β对佩罗尼氏斑块成纤维细胞中基质金属蛋白酶及其组织抑制剂的钙非依赖性差异调节
J Urol. 2008 Jun;179(6):2447-55. doi: 10.1016/j.juro.2008.01.093. Epub 2008 Apr 23.
3
New in vivo model to assess macroscopic, histological, and molecular changes in Peyronie's disease.评估佩罗尼病宏观、组织学和分子变化的新体内模型。
Andrology. 2022 Jan;10(1):154-165. doi: 10.1111/andr.13092. Epub 2021 Sep 8.
4
Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.转化生长因子(TGF)-β信号通路的改变是佩罗尼氏病发病机制中的一个潜在因素。
Eur Urol. 2007 Jan;51(1):255-61. doi: 10.1016/j.eururo.2006.05.002. Epub 2006 May 19.
5
MicroRNA-29b attenuates fibrosis in a rat model of Peyronie's disease.微小RNA-29b减轻佩罗尼氏病大鼠模型中的纤维化。
Andrology. 2025 Feb;13(2):396-406. doi: 10.1111/andr.13672. Epub 2024 Jun 24.
6
Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.在佩罗尼氏病大鼠模型中,通过转化生长因子-β/信号转导和转录激活因子信号通路,利用真空勃起装置减小佩罗尼氏样斑块大小。
Andrologia. 2018 Sep;50(7):e13051. doi: 10.1111/and.13051. Epub 2018 May 28.
7
Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie's disease.转化生长因子β蛋白表达增加在佩罗尼氏病发病机制中的作用
Egypt J Immunol. 2005;12(1):1-8.
8
Review of Management Options for Patients With Atypical Peyronie's Disease.《不典型性佩罗尼病患者的治疗选择综述》。
Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17.
9
Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.评估一氧化氮合酶和精氨酸酶在诱导大鼠佩罗尼氏样病症中的作用。
J Androl. 2001 May-Jun;22(3):497-506.
10
Basic fibroblast growth factor expression in Peyronie's disease.佩罗尼氏病中碱性成纤维细胞生长因子的表达
J Urol. 2001 Feb;165(2):419-23. doi: 10.1097/00005392-200102000-00016.

引用本文的文献

1
Acute Phase Peyronie's Disease: Where Do We Stand?佩罗尼氏病急性期:我们目前的状况如何?
Cureus. 2024 Aug 17;16(8):e67054. doi: 10.7759/cureus.67054. eCollection 2024 Aug.
2
Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.揭示佩罗尼氏病的分子特征:一项全面的叙述性综述。
Int J Impot Res. 2024 Dec;36(8):801-808. doi: 10.1038/s41443-024-00845-2. Epub 2024 Mar 7.
3
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.与佩罗尼病发病机制相关的分子机制和危险因素。

本文引用的文献

1
Hyaluronic acid-carboxymethylcellulose reduced postoperative bowel adhesions following laparoscopic urologic pelvic surgery: a prospective, randomized, controlled, single-blind study.透明质酸-羧甲基纤维素减少腹腔镜泌尿外科盆腔手术后的肠粘连:一项前瞻性、随机、对照、单盲研究。
BMC Urol. 2016 Jun 10;16(1):28. doi: 10.1186/s12894-016-0149-3.
2
Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.乙酰肝素酶2可减弱头颈肿瘤的血管生成及生长。
Cancer Res. 2016 May 1;76(9):2791-801. doi: 10.1158/0008-5472.CAN-15-1975. Epub 2016 Mar 24.
3
Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study.
Int J Mol Sci. 2023 Jun 14;24(12):10133. doi: 10.3390/ijms241210133.
4
Characterization of a novel rabbit model of Peyronie's disease.佩罗尼氏病新型兔模型的特征描述。
Int J Impot Res. 2024 May;36(3):269-274. doi: 10.1038/s41443-023-00671-y. Epub 2023 Feb 13.
5
Peyronie's Disease: An Outcomes-Based Guide to Non-Surgical and Novel Treatment Modalities.佩罗尼氏病:基于结果的非手术及新型治疗方式指南
Res Rep Urol. 2023 Feb 2;15:55-67. doi: 10.2147/RRU.S278796. eCollection 2023.
6
The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review.免疫微环境与干细胞疗法在 Peyronie 病中的新作用:系统叙事性综述。
Int J Mol Sci. 2023 Jan 1;24(1):777. doi: 10.3390/ijms24010777.
7
New insights into the pathogenesis of Peyronie's disease: A narrative review.佩罗尼氏病发病机制的新见解:一项叙述性综述。
Chronic Dis Transl Med. 2020 Jul 27;6(3):165-181. doi: 10.1016/j.cdtm.2020.06.001. eCollection 2020 Sep.
局部注射透明质酸治疗 Peyronie 病患者:一项前瞻性、多中心、初步研究结果。
Sex Med. 2016 Jun;4(2):e83-8. doi: 10.1016/j.esxm.2016.01.002. Epub 2016 Mar 13.
4
Hyaluronic Acid in Inflammation and Tissue Regeneration.炎症与组织再生中的透明质酸
Wounds. 2016 Mar;28(3):78-88.
5
Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.透明质酸酶1和2在内源性透明质酸周转中的各自作用。
FASEB J. 2016 Jun;30(6):2108-14. doi: 10.1096/fj.201500178R. Epub 2016 Feb 17.
6
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.关于乙酰肝素酶的最新数据:聚焦纤维化、炎症和癌症。
Biomol Concepts. 2015 Dec;6(5-6):415-21. doi: 10.1515/bmc-2015-0021.
7
The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms.乙酰肝素酶表达谱可区分分化型甲状腺癌与良性肿瘤。
PLoS One. 2015 Oct 21;10(10):e0141139. doi: 10.1371/journal.pone.0141139. eCollection 2015.
8
High and low molecular weight hyaluronic acid differentially influence macrophage activation.高分子量和低分子量透明质酸对巨噬细胞活化有不同影响。
ACS Biomater Sci Eng. 2015 Jul 13;1(7):481-493. doi: 10.1021/acsbiomaterials.5b00181.
9
Fluorescence resonance energy transfer (FRET) and proximity ligation assays reveal functionally relevant homo- and heteromeric complexes among hyaluronan synthases HAS1, HAS2, and HAS3.荧光共振能量转移(FRET)和邻近连接分析揭示了透明质酸合酶HAS1、HAS2和HAS3之间功能相关的同源和异源复合物。
J Biol Chem. 2015 May 1;290(18):11479-90. doi: 10.1074/jbc.M115.640581. Epub 2015 Mar 20.
10
Immunohistochemical expression of heparanases 1 and 2 in benign tissue and in invasive neoplasia of the endometrium: a case-control study.乙酰肝素酶1和2在子宫内膜良性组织及浸润性肿瘤中的免疫组化表达:一项病例对照研究。
Int J Gynecol Cancer. 2015 Feb;25(2):269-78. doi: 10.1097/IGC.0000000000000329.